Reperfusion induced injury: manifestations, mechanisms, and clinical relevance.
about
Severe electrolyte disorders following cardiac surgery: a prospective controlled observational studyMechanisms of oxidative stress and myocardial protection during open-heart surgeryIschemia-reperfusion-induced changes in sarcolemmal Na+/K+-ATPase are due to the activation of calpain in the heartEffects of N-n-butyl haloperidol iodide on L-type calcium channels and intracellular free calcium in rat ventricular myocytes.Treatment with the C5a receptor antagonist ADC-1004 reduces myocardial infarction in a porcine ischemia-reperfusion model.Sulfaphenazole protects heart against ischemia-reperfusion injury and cardiac dysfunction by overexpression of iNOS, leading to enhancement of nitric oxide bioavailability and tissue oxygenation.Thrombogenesis in myocardial infarction and related syndromes: the role of molecular markers in diagnosis and management.Recombinant complement receptor 2 radiolabeled with [99mTc(CO)3]+: a potential new radiopharmaceutical for imaging activated complementClinical and procedural predictors of no-reflow in patients with acute myocardial infarction after primary percutaneous coronary intervention.Cardioprotection: emerging pharmacotherapy.CD59a deficiency exacerbates ischemia-reperfusion injury in mice.Cyclosporine A reduces microvascular obstruction and preserves left ventricular function deterioration following myocardial ischemia and reperfusion.The nitric oxide donor S-nitroso-N-acetylpenicillamine (SNAP) increases free radical generation and degrades left ventricular function after myocardial ischemia-reperfusion.The discovery of LOX-1, its ligands and clinical significance.Attenuation of ischemia-reperfusion injury by ascorbic acid in the canine renal transplantation.Mild Type 2 Diabetes Mellitus Reduces the Susceptibility of the Heart to Ischemia/Reperfusion Injury: Identification of Underlying Gene Expression Changes.Myocardial ischemia, reperfusion, and infarction in chronically instrumented, intact, conscious, and unrestrained miceACE inhibitors - angiotensin II receptor antagonists: A useful combination therapy for ischemic heart disease.Phospholipid-mediated signaling systems as novel targets for treatment of heart disease.Intermittent hypoxia has organ-specific effects on oxidative stressThe effect of high dose melatonin on cardiac ischemia- reperfusion Injury.Korean Red Ginseng Induced Cardioprotection against Myocardial Ischemia in Guinea Pig.The Protective Role of the TOPK/PBK Pathway in Myocardial Ischemia/Reperfusion and H₂O₂-Induced Injury in H9C2 Cardiomyocytes.Myocardial protection during minimally invasive cardiac surgery through right mini-thoracotomy.Targeting phosphodiesterase 5 as a therapeutic option against myocardial ischaemia/reperfusion injury and for treating heart failure.Reperfusion-induced sustained ventricular tachycardia, leading to ventricular fibrillation, in chronically instrumented, intact, conscious mice.Intracoronary adenosine versus intravenous adenosine during primary PCI for ST-elevation myocardial infarction: which one offers better outcomes in terms of microvascular obstruction?Predominant role for C5b-9 in renal ischemia/reperfusion injury.Myocardial reperfusion injury: fact or myth? A 1993 appraisal of a seemingly endless controversy.ATP-induced cardioprotection against myocardial ischemia/reperfusion injury is mediated through the RISK pathway.Pharmacology and pharmacokinetics of LEX 032, a bioengineered serpin: the first of a potential new class of drugs.Myocardial protection during minimally invasive mitral valve surgery: strategies and cardioplegic solutions.Effect of preconditioning temperature on cardioprotection during global ischemia-reperfusion in the rat heart.Cardioprotective effects of benazepril, an angiotensin-converting enzyme inhibitor, in an ischaemia-reperfusion model of myocardial infarction in rats.A no-reflow prediction model in patients with ST-elevation acute myocardial infarction and primary drug-eluting stenting.Dose-dependent protection of cardiac function by propofol during ischemia and early reperfusion in rats: effects on 15-F2t-isoprostane formation.Adenosine A1 receptor activation reduces myocardial reperfusion effects on intrinsic cardiac nervous system.Protective effect of melatonin on myocardial infarction.Inhibition of PLC improves postischemic recovery in isolated rat heart.Strategies for the regulation of intracellular calcium in ischemic heart disease.
P2860
Q24801451-A43486E4-7F09-4502-BE43-4B5581B709D7Q26781772-1340D0C9-AC13-4577-BA69-0C6655C5E584Q28583177-D0E47687-A5A7-4489-AA77-220787B75EC5Q33286031-48703AF4-28F2-4CA2-BF77-472FB4802133Q33704554-7F68FE48-81A5-4112-B005-A6D940376D8AQ33772589-D5B9483E-A1C5-4695-91F5-146D593422DBQ33868312-61C8A175-B1B9-4B23-AF05-F5205B978A20Q33873704-483800CE-AD29-4797-BB79-F9C2A97BFA23Q34032366-69AB96E6-72B6-40F7-9A0E-987362B43D68Q34241006-CE3CFE40-6185-4970-AE01-A940823B536BQ35103059-32A430A1-17DF-4F56-B87F-DAA18577751FQ35126767-6B5F5B82-6D12-4E09-8465-52B34DED1399Q35129243-68512891-71CA-4AFC-B1B7-024371EB9174Q35475499-1F462264-84C7-450C-B864-DDEF3C344A41Q35622465-B3F56CE5-B3DA-4696-8D2A-1DD787136E66Q35851658-FE20B33A-51C7-44CB-8CEE-6E0C8B7D3A47Q36042854-812D62BF-1058-4536-A59A-8B79E7F14849Q36726341-0F4E7C3D-711B-4866-928D-4D118CE25FECQ36814743-D19A4179-89EA-4482-A58A-A144DD47A2CDQ36956636-7574C1B2-33A1-4941-B036-6B5979054025Q37041189-8BA9A539-70DE-4316-BF75-3D8B9E5E1E7EQ37090085-7143B0C1-C836-4885-BE9C-3AE953FC17DBQ38791620-6CDE015F-2512-422B-98E4-42804F07C66DQ38887945-603618D1-4206-4542-A3AC-07D7E10E4E46Q39141728-05701892-52E5-4F31-BDF2-EE774CED4039Q39204821-AEDA4C15-C215-442E-9EA9-481FBB923F5DQ39769940-C42EC3F3-227E-490F-8825-6A53AE69E164Q40437461-E09C6AA2-FE3C-4ABB-9A90-4B33F52FDF19Q40671261-75028406-2171-4689-9CC6-AE7133C20D9EQ41196236-B4771110-05AE-4ADB-876E-4B1BAE19CA7EQ41501871-B593A8E4-F488-4201-B203-6FD6A2D06271Q42831312-EE17BBF5-9059-4229-AFAD-5A9FEF2A461BQ43014461-298371DE-8C9D-4130-8CEA-9B16CCA3FBD8Q43212275-7CFA18F8-0CC4-4EFC-BF4C-DAB6414F995EQ44127712-6C76253D-77AD-444F-AE83-6BB44A85B461Q44382630-1071DADC-17AA-4118-87DD-819A3FE8F98CQ44391170-F5800594-CCA1-4033-8BC2-E21453087A8CQ44392713-1F95A6A9-CC2B-48CE-BC04-652C237A464EQ45009046-7C44AE14-BF37-475B-B92E-2E3F5CB43B81Q45168252-01A3DAA3-775D-4C40-B2FB-D0012534B594
P2860
Reperfusion induced injury: manifestations, mechanisms, and clinical relevance.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Reperfusion induced injury: manifestations, mechanisms, and clinical relevance.
@ast
Reperfusion induced injury: manifestations, mechanisms, and clinical relevance.
@en
type
label
Reperfusion induced injury: manifestations, mechanisms, and clinical relevance.
@ast
Reperfusion induced injury: manifestations, mechanisms, and clinical relevance.
@en
prefLabel
Reperfusion induced injury: manifestations, mechanisms, and clinical relevance.
@ast
Reperfusion induced injury: manifestations, mechanisms, and clinical relevance.
@en
P356
P1476
Reperfusion induced injury: manifestations, mechanisms, and clinical relevance.
@en
P2093
P304
P356
10.1093/CVR/26.2.101
P577
1992-02-01T00:00:00Z